Results 301 to 310 of about 524,302 (394)
Through network pharmacology and molecular docking, it has been discovered that CA can target MAOB, among other proteins, to exert a therapeutic effect in IBS. In vivo, CA lowered visceral hypersensitivity, anxiety and depression‐like behaviors, and fecal water content, highlighting its therapeutic potential for IBS via anti‐inflammatory pathways ...
Qingyang Yu +4 more
wiley +1 more source
Gut microbiota and metabolic signatures of anxiety in ulcerative colitis: a cross-sectional study. [PDF]
Ping Y +15 more
europepmc +1 more source
Succinate promotes macrophage to the M1 phenotype in the mouse mononuclear macrophage leukemia cells (Raw264.7 cells) and neonatal mice with NEC. Succinate activates the phosphatidylinositol 3‐kinase/protein kinase B (PI3K/AKT) pathway via succinate recepter 1 (SUCNR1), promoting M1 polarization of NEC intestinal macrophages.
Sha Liu +6 more
wiley +1 more source
Safety evaluation of etrasimod for ulcerative colitis based on the FAERS database. [PDF]
Guo Q, Shan M, Gao W.
europepmc +1 more source
Phytochemical Properties of Crataegus azarolus Berries Decoction Extract and Evaluation of its Protective Activity Against Acetic Acid-Induced Ulcerative Colitis in Rats [PDF]
Houcem Sammari +5 more
openalex +1 more source
An overview and categorization of man‐made per‐ or polyfluoroalkyl substances (PFASs) including low‐molar‐mass and high‐molar‐mass fluorochemicals, and their international regulations is presented. Though certain PFASs are toxic, bioaccumulative and cross the human cellular membranes, others, such as fluoropolymers, are safe, reliable and involved in ...
Bruno Améduri
wiley +1 more source
Coexistence of ulcerative colitis and neurofibromatosis type 1: a case report and literature review. [PDF]
Huang X +5 more
europepmc +1 more source

